Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 17.27
-0.58 (-3.25%)
Mar 3, 2026, 4:00 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 356.23 million as of March 4, 2026. Its market cap has increased by 194.28% in one year.
Market Cap
356.23M
Enterprise Value
308.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
17.27
Market Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 356.23M, an increase of 505.50%. That is a compound annual growth rate of 48.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 356.23M | 190.95% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
| Aug 19, 2021 | 58.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 1.09B |
| Eupraxia Pharmaceuticals | 683.63M |
| NervGen Pharma | 426.12M |
| Helix BioPharma | 150.46M |
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 73.41M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 58.99M |